What If You Need Multiple CDMO Partnerships? (A Discussion On Resilience And Risk Mitigation)

As if outsourcing development and manufacturing wasn’t difficult enough, how does a biopharma organization (of any size) handle a multi-CDMO coordination? Sure, most talk today is about simplifying supply chains. But the need for redundancy, risk management, and finding the best partners for specific services remains. And drug programs have grown more complex; sponsors may still desire or be forced to spread work across multiple CDMOs, sometimes across the globe. Our panel (Lynn Cinelli, (former) VP Global Biologics Supply Chain at Bristol Myers Squibb; Mani Sundararajan, former VP Tech Ops and Global Outsourcing executive at BMS, AstraZeneca, Shire; Firelli Alonso, (former) Senior Director of External Supply at Pfizer) explain how to manage communication, scheduling and workflow, and accountability.